Analysts’ Viewpoint on Market Scenario
Rise in the incidence of acute respiratory distress syndrome (ARDS) is expected to drive the acute respiratory distress syndrome devices market size from 2022 to 2031. ARDS is a serious lung condition that causes fluid to build up in the air sacs of the lungs. Elderly people are highly susceptible to suffer from this condition. Therefore, surge in the geriatric population is anticipated to boost market expansion during the forecast period.
Investment in the R&D of new devices is estimated to offer lucrative growth opportunities for vendors in the industry. However, high costs and a lack of trained personnel are likely to limit adoption of ARDS devices in the near future. Vendors are focused on the launch of affordable devices to increase their acute respiratory distress syndrome devices market share.
Acute respiratory distress syndrome (ARDS) is a severe lung condition that can occur as a complication of a wide range of underlying conditions, including sepsis, pneumonia, and trauma. It is characterized by inflammation and fluid accumulation in the lungs, which can lead to difficulty in breathing and low oxygen levels in the blood.
ARDS can be life-threatening if not treated promptly and effectively. Various devices and equipment are used for the treatment of ARDS including mechanical ventilators, oxygen therapy devices, and extracorporeal membrane oxygenation (ECMO) systems. ARDS devices are typically employed in critical care settings such as intensive care units (ICUs) and emergency departments.
Aging population and surge in cases of chronic diseases are estimated to boost the demand for ARDS devices in the next few years. People above the age of 60 years are at high risk of ARDS and other chronic conditions. According to the United Nations, the global population aged 60 years and above is projected to more than double by 2050.
Older adults are susceptible to various chronic diseases such as obesity, diabetes, and heart disease. Additionally, they are more likely to have weakened immune systems, making them more prone to infections such as pneumonia. According to the World Health Organization (WHO), ARDS affects around 150 million people globally every year. Thus, high prevalence of ARDS is estimated to aid in acute respiratory distress syndrome devices business growth in the near future.
Major acute respiratory distress syndrome device manufacturers are focused on investing significantly in the R&D of new products. Advanced ARDS devices are likely to improve patient outcomes, reduce the length of hospital stays, and lower healthcare costs.
In June 2020, Hamilton Medical launched the Hamilton-T1 ventilator with High-Frequency Oscillation Ventilation (HFOV) technology to provide advanced ventilation support for critically ill patients. HFOV is a form of mechanical ventilation that delivers rapid, small tidal volume breaths at a high frequency. This helps minimize lung injury and improve patient outcomes. Therefore, development and launch of new devices is projected to augment the acute respiratory distress syndrome devices market trajectory in the next few years.
According to the latest acute respiratory distress syndrome devices market trends, the diagnostic & monitoring devices type segment is anticipated to hold largest share during the forecast period. Diagnostic & monitoring devices are utilized for the treatment and management of ARDS. High prevalence of ARDS is likely to boost the demand for these devices in the near future.
Diagnostic & monitoring devices measure oxygen saturation levels, lung function, and other vital signs. This enables healthcare professionals to initiate prompt and effective treatment. Early detection and treatment of ARDS can improve patient outcomes and reduce the length of hospital stays.
The hospitals end-user segment is estimated to dominate the acute respiratory distress syndrome devices market during the forecast period. Hospitals are the primary providers of care for patients with ARDS. These patients typically require hospitalization and close monitoring, which is only possible in a hospital setting.
Hospitals possess the required infrastructure and resources to support the use of ARDS devices. They also have the necessary personnel, including doctors, nurses, and respiratory therapists, needed to operate these devices. Robust infrastructure further allows hospitals to offer the best possible care for ARDS patients.
According to the latest acute respiratory distress syndrome devices market analysis, North America is anticipated to hold largest share during the forecast period. Increase in the incidence of ARDS and other respiratory disorders, rise in healthcare expenditure, and the presence of major vendors are likely to boost market progress in the near future.
The industry in Asia Pacific market is projected to grow at a significant rate during the forecast period. High prevalence of respiratory disorders, surge in the geriatric population, and growth in awareness regarding advanced ARDS devices are expected to augment market statistics in the region.
Major vendors have been profiled in the acute respiratory distress syndrome devices market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
Koninklijke Philips N.V., Medtronic, Fisher & Paykel Healthcare Limited, Drägerwerk AG & Co. KGaA, Smiths Medical (ICU Medical), Hamilton Medical, GE Healthcare, ResMed, and Getinge AB are key entities operating in this industry. Companies are focused on adopting various organic and inorganic strategies to broaden their regional presence.
|
Attribute |
Detail |
|
Market Size Value in 2021 |
US$ 311.1 Mn |
|
Market Forecast Value in 2031 |
More than US$ 651.6 Mn |
|
Compound Annual Growth Rate (CAGR) |
7.8% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2021 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global market was valued at US$ 311.1 Mn in 2021.
It is projected to reach more than US$ 651.6 Mn by 2031.
It is anticipated to be 7.8% from 2022 to 2031.
Rise in incidence of Acute Respiratory Distress Syndrome (ARDS) and increase in geriatric population.
The diagnostic & monitoring devices segment held largest share in 2021.
North America is expected to account for major share from 2022 to 2031.
Koninklijke Philips N.V., Medtronic, Fisher & Paykel Healthcare Limited, Drägerwerk AG & Co. KGaA, Smiths Medical (ICU Medical), Hamilton Medical, GE Healthcare, ResMed, and Getinge AB.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Acute Respiratory Distress Syndrome Devices Market
4. Market Overview
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Global Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast, 2017–2031
5. Key Insight
5.1. Disease Incidence and prevalence
5.2. Key Mergers & Acquisitions
5.3. New Product Launches and FDA Approvals
5.4. COVID-19 Impact Analysis
6. Global Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Global Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Type, 2017–2031
6.3.1. Therapeutic Devices
6.3.1.1. Mechanical Ventilators
6.3.1.2. PAP
6.3.1.3. Others
6.3.2. Diagnostic & Monitoring Devices
6.4. Global Acute Respiratory Distress Syndrome Devices Market Attractiveness, by Type
7. Global Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Global Acute Respiratory Distress Syndrome Devices Market Value Forecast, by End-user, 2017–2031
7.3.1. Hospitals
7.3.2. Specialty Centers
7.3.3. Others
7.4. Global Acute Respiratory Distress Syndrome Devices Market Attractiveness, by End-user
8. Global Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Acute Respiratory Distress Syndrome Devices Market Attractiveness, by Region
9. North America Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. North America Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Type, 2017–2031
9.2.1. Therapeutic Devices
9.2.1.1. Mechanical Ventilators
9.2.1.2. PAP
9.2.1.3. Others
9.2.2. Diagnostic & Monitoring Devices
9.3. North America Acute Respiratory Distress Syndrome Devices Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals
9.3.2. Specialty Centers
9.3.3. Others
9.4. North America Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. North America Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis
9.5.1. By Type
9.5.2. By End-user
9.5.3. By Country
10. Europe Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Europe Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Type, 2017–2031
10.2.1. Therapeutic Devices
10.2.1.1. Mechanical Ventilators
10.2.1.2. PAP
10.2.1.3. Others
10.2.2. Diagnostic & Monitoring Devices
10.3. Europe Acute Respiratory Distress Syndrome Devices Market Value Forecast, by End-user, 2017–2031
10.3.1. Hospitals
10.3.2. Specialty Centers
10.3.3. Others
10.4. Europe Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis
10.5.1. By Type
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Type, 2017–2031
11.2.1. Therapeutic Devices
11.2.1.1. Mechanical Ventilators
11.2.1.2. PAP
11.2.1.3. Others
11.2.2. Diagnostic & Monitoring Devices
11.3. Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value Forecast, by End-user, 2017–2031
11.3.1. Hospitals
11.3.2. Specialty Centers
11.3.3. Others
11.4. Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis
11.5.1. By Type
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Latin America Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Type, 2017–2031
12.2.1. Therapeutic Devices
12.2.1.1. Mechanical Ventilators
12.2.1.2. PAP
12.2.1.3. Others
12.2.2. Diagnostic & Monitoring Devices
12.3. Latin America Acute Respiratory Distress Syndrome Devices Market Value Forecast, by End-user, 2017–2031
12.3.1. Hospitals
12.3.2. Specialty Centers
12.3.3. Others
12.4. Latin America Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis
12.5.1. By Type
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Type, 2017–2031
13.2.1. Therapeutic Devices
13.2.1.1. Mechanical Ventilators
13.2.1.2. PAP
13.2.1.3. Others
13.2.2. Diagnostic & Monitoring Devices
13.3. Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value Forecast, by End-user, 2017–2031
13.3.1. Hospitals
13.3.2. Specialty Centers
13.3.3. Others
13.4. Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis
13.5.1. By Type
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of Companies)
14.2. Market Share Analysis By Company (2021)
14.3. Company Profiles
14.3.1. Koninklijke Philips N.V.
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Financial Overview
14.3.1.5. Strategic Overview
14.3.2. Medtronic
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Financial Overview
14.3.2.5. Strategic Overview
14.3.3. Fisher & Paykel Healthcare Limited
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Financial Overview
14.3.3.5. Strategic Overview
14.3.4. Drägerwerk AG & Co. KGaA
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Financial Overview
14.3.4.5. Strategic Overview
14.3.5. Smiths Medical (ICU Medical)
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Financial Overview
14.3.5.5. Strategic Overview
14.3.6. Hamilton Medical
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Strategic Overview
14.3.7. GE HealthCare
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.8. ResMed
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Strategic Overview
14.3.9. Getinge AB
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Strategic Overview
List of Tables
Table 01: Global Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 02: Global Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031
Table 03: Global Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 06: North America Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031
Table 07: North America Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 08: North America Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 09: Europe Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 10: Europe Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031
Table 11: Europe Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 12: Europe Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 13: Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 14: Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031
Table 15: Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Latin America Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 18: Latin America Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031
Table 19: Latin America Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 20: Latin America Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 21: Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 22: Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031
Table 23: Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 24: Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
List of Figures
Figure 01: Global Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) and Distribution (%), by Region, 2021 and 2031
Figure 02: Global Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn), by Type, 2021
Figure 03: Market Snapshot - Top 2 Trends
Figure 04: Market Overview
Figure 05: Global Acute Respiratory Distress Syndrome Devices Market Value Share, by Type, 2021
Figure 06: Global Acute Respiratory Distress Syndrome Devices Market Value Share, by End-user, 2021
Figure 07: Global Acute Respiratory Distress Syndrome Devices Market Value Share, by Region, 2021
Figure 08: Global Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 09: Global Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by Type, 2021 and 2031
Figure 10: Global Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) and Y-o-Y Growth, by Therapeutic Devices, 2017–2031
Figure 11: Global Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) and Y-o-Y Growth, by Diagnostic & Monitoring Devices, 2017–2031
Figure 12: Global Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by Type, 2021–2031
Figure 13: Global Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 14: Global Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2017–2031
Figure 15: Global Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Specialty Centers, 2017–2031
Figure 16: Global Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2031
Figure 17: Global Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by End-user, 2021–2031
Figure 18: Global Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by Region, 2021 and 2031
Figure 19: Global Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by Region, 2021–2031
Figure 20: North America Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 21: North America Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by Type, 2021 and 2031
Figure 22: North America Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by Type, 2021–2031
Figure 23: North America Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 24: North America Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by End-user, 2021–2031
Figure 25: North America Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by Country, 2021 and 2031
Figure 26: North America Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by Country, 2021–2031
Figure 27: Europe Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 28: Europe Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by Type, 2021 and 2031
Figure 29: Europe Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by Type, 2021–2031
Figure 30: Europe Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 31: Europe Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by End-user, 2021–2031
Figure 32: Europe Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 33: Europe Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 34: Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 35: Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by Type, 2021 and 2031
Figure 36: Asia Pacific Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by Type, 2021–2031
Figure 37: Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 38: Asia Pacific Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by End-user, 2021–2031
Figure 39: Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 40: Asia Pacific Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 41: Latin America Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 42: Latin America Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by Type, 2021 and 2031
Figure 43: Latin America Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by Type, 2021–2031
Figure 44: Latin America Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 45: Latin America Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by End-user, 2021–2031
Figure 46: Latin America Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 47: Latin America Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 48: Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 49: Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by Type, 2021 and 2031
Figure 50: Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by Type, 2021–2031
Figure 51: Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 52: Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by End-user, 2021–2031
Figure 53: Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 54: Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Acute Respiratory Distress Syndrome Devices Market
